T.A. Fleisher

1.5k total citations
19 papers, 1.2k citations indexed

About

T.A. Fleisher is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, T.A. Fleisher has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in T.A. Fleisher's work include Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (2 papers). T.A. Fleisher is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (2 papers). T.A. Fleisher collaborates with scholars based in United States, Ukraine and Hungary. T.A. Fleisher's co-authors include David L. Nelson, T. Uchiyama, Harry L. Malech, T. A. Waldmann, Sudhir Sekhsaria, Sarah J. Vowells, Meir Shalit, Gary S. Hoffman, Gail S. Kerr and Claire W. Hallahan and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

T.A. Fleisher

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.A. Fleisher United States 11 570 290 256 168 138 19 1.2k
Lap-Ping Chung United Kingdom 21 585 1.0× 423 1.5× 218 0.9× 93 0.6× 156 1.1× 27 1.4k
S. Kishimoto Japan 19 575 1.0× 349 1.2× 101 0.4× 231 1.4× 119 0.9× 61 1.5k
Jacinto J. Vazquez United States 14 270 0.5× 303 1.0× 164 0.6× 92 0.5× 154 1.1× 25 1.1k
G Damiani Italy 21 416 0.7× 343 1.2× 86 0.3× 141 0.8× 248 1.8× 52 1.1k
AD Schreiber United States 19 616 1.1× 513 1.8× 98 0.4× 84 0.5× 534 3.9× 44 1.6k
Marleen M. Voorhorst‐Ogink Netherlands 13 552 1.0× 464 1.6× 174 0.7× 54 0.3× 217 1.6× 17 1.2k
Yasumichi Hitoshi Japan 22 1.1k 1.9× 814 2.8× 111 0.4× 242 1.4× 122 0.9× 48 2.1k
Gilles Bessou France 24 1.3k 2.4× 447 1.5× 355 1.4× 159 0.9× 36 0.3× 38 2.0k
Judy Geissler Netherlands 28 1.0k 1.8× 575 2.0× 187 0.7× 138 0.8× 460 3.3× 52 1.9k
J Van Snick Belgium 23 1.1k 2.0× 370 1.3× 69 0.3× 252 1.5× 306 2.2× 33 1.7k

Countries citing papers authored by T.A. Fleisher

Since Specialization
Citations

This map shows the geographic impact of T.A. Fleisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.A. Fleisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.A. Fleisher more than expected).

Fields of papers citing papers by T.A. Fleisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.A. Fleisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.A. Fleisher. The network helps show where T.A. Fleisher may publish in the future.

Co-authorship network of co-authors of T.A. Fleisher

This figure shows the co-authorship network connecting the top 25 collaborators of T.A. Fleisher. A scholar is included among the top collaborators of T.A. Fleisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.A. Fleisher. T.A. Fleisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fleisher, T.A.. (2011). Hypomorphic Rag Mutations Can Cause Destructive Midline Granulomatous Disease. PEDIATRICS. 128(Supplement). S141–S141. 2 indexed citations
2.
Heim, K., T.A. Fleisher, David F. Stroncek, et al.. (2010). The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion. 51(6). 1154–1162. 24 indexed citations
3.
Fleisher, T.A., Stephen E. Straus, & Jack Bleesing. (2001). A genetic disorder of lymphocyte apoptosis involving the fas pathway: The autoimmune lymphoproliferative syndrome. Current Allergy and Asthma Reports. 1(6). 534–540. 5 indexed citations
4.
Simone, Nicole L., Alan T. Remaley, Lu Charboneau, et al.. (2000). Sensitive Immunoassay of Tissue Cell Proteins Procured by Laser Capture Microdissection. American Journal Of Pathology. 156(2). 445–452. 113 indexed citations
5.
Foss, Francine M., James L. Mulshine, T.A. Fleisher, et al.. (1998). Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.. PubMed. 4(11). 2691–700. 33 indexed citations
6.
Sobel, Douglas O., T.A. Fleisher, & Dennis G. Karounos. (1997). Characterization of a Human T Cell Line Reactive to a 52 kDa Islet Protein. Journal of Autoimmunity. 10(4). 387–394. 1 indexed citations
7.
Ahuja, Seema S., et al.. (1996). Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer. The Journal of Immunology. 156(11). 4345–4353. 10 indexed citations
8.
Vowells, Sarah J., Sudhir Sekhsaria, Harry L. Malech, Meir Shalit, & T.A. Fleisher. (1995). Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. Journal of Immunological Methods. 178(1). 89–97. 339 indexed citations
9.
Garavelli, Pietro Luigi, et al.. (1995). Serum antibody detected by fluorescent antibody test in patients with symptomatic Blastocystis hominis infection.. PubMed. 86(10). 398–400. 5 indexed citations
10.
Gaspari, Anthony A., T.A. Fleisher, & Kenneth H. Kraemer. (1993). Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.. Journal of Clinical Investigation. 92(3). 1135–1142. 64 indexed citations
11.
Kerr, Gail S., et al.. (1993). Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with wegener's granulomatosis. Arthritis & Rheumatism. 36(3). 365–371. 221 indexed citations
12.
Attallah, Abdelfattah M., et al.. (1987). Immunological Activities of Recombinant Interferon-α 2 and Its A Fragment. Journal of Interferon Research. 7(2). 223–229. 4 indexed citations
13.
Murrell, K. Darwin, et al.. (1987). Parasitic Modulation of Host Immune Mechanisms in Schistosomiasis. International Archives of Allergy and Immunology. 84(1). 1–9. 4 indexed citations
14.
Golding, Basil, George C. Tsokos, T.A. Fleisher, Andrew V. Muchmore, & R. Michael Blaese. (1986). The role of nonactivated and interferon-gamma activated monocytes in regulating normal and SLE patient B cell responses to TNP-Brucella abortus.. The Journal of Immunology. 137(1). 103–107. 5 indexed citations
16.
Greene, W C, T.A. Fleisher, David L. Nelson, & Thomas A. Waldmann. (1982). Production of human suppressor T cell hybridomas.. The Journal of Immunology. 129(5). 1986–1992. 16 indexed citations
17.
Fleisher, T.A., W C Greene, T. Uchiyama, et al.. (1981). Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line.. The Journal of Experimental Medicine. 154(1). 156–167. 20 indexed citations
19.
Attallah, Abdelfattah M., et al.. (1980). Proliferative and functional aspects of interferon-treated human normal and neoplastic T and B cells. British Journal of Cancer. 42(3). 423–429. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026